2008 Press releases
Positive ELACYT Phase II Results - Data presented at ASH
Clavis Pharma ASA (OSE: CLAVIS) announces positive interim clinical phase II results for ELACYT single agent therapy in patients with late stage acute myeloid leukaemia (AML).
Third Quarter Report 2008
"Three products in clinical development" - Clavis Pharma ASA (OSE: CLAVIS) announced today the results for the third quarter 2008 ...
Clinical development of ELACYT in haematology expanded
ELACYT Clinical Update
Promising Results for Oral CP-4126
ELACYT™ clinical results presented at ASCO
Clavis Pharma ASA to present Phase I clinical results from ELACYT in patients with cancers of the blood